A comparative study between transcutaneous electrical nerve stimulation and pulsed electromagnetic field therapy in the management of post-herpetic neuralgia of the sciatic nerve.
Featured on Physle Daily · Wednesday, 28 October 2026
When nerve pain lingers after shingles affects the sciatic nerve, physiotherapists often reach for electrotherapy alongside standard treatment, but it has been unclear whether one modality has an edge over another. This trial compared two such add-ons, transcutaneous electrical nerve stimulation (TENS) and pulsed electromagnetic field therapy (PEMFT), each combined with conventional physical therapy, in 56 patients over eight weeks. Both groups showed significant drops in pain ratings and in the dose of carbamazepine (a medication used for nerve pain) they needed, compared with before treatment. However, when the two groups were compared against each other, there was no statistically significant difference in either outcome.
The main limitation is the small sample size, which limits confidence in ruling out a real difference between the two approaches.
If you or someone you know has ongoing nerve pain in the leg following shingles, you may have heard of electrical stimulation treatments like TENS or magnetic field therapy being used alongside regular physiotherapy. This study looked at 56 people who received one or the other method, added to standard physical therapy, over eight weeks. Both groups reported less pain and needed smaller doses of their nerve pain medication by the end of treatment, compared to how they started.
But when researchers compared the two treatments to each other, neither one looked clearly better than the other. It's worth keeping in mind that this was a fairly small study, with only 56 people included, so these results give an early picture rather than a definitive answer about which treatment, if either, works better.
This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.
This randomised trial addresses a specific clinical question: when choosing an electrotherapy add-on for post-herpetic neuralgia affecting the sciatic nerve, does TENS or PEMFT offer better outcomes when layered onto conventional physical therapy? Fifty-six patients were randomised equally to receive either TENS or PEMFT alongside the same base physical therapy programme, three sessions weekly for eight weeks, with pain (VAS) and carbamazepine dose as outcomes. Both groups showed statistically significant within-group improvements in pain and medication use, but the abstract reports no statistically significant between-group difference in either outcome (mean VAS difference -0.27, mean carbamazepine difference -6.07). This informs clinical reasoning by suggesting that, in this small sample, neither modality demonstrated superiority over the other as an adjunct, though the trial does not establish equivalence or that either modality independently caused the improvement, since there was no non-intervention comparison arm isolating the add-on effect from the shared conventional therapy. The principal limitation is sample size: with only 56 participants split across two arms, the study has limited capacity to detect a true difference between modalities, and the double-blinded design detail is not elaborated beyond being stated.
These findings should be read as preliminary rather than practice-changing.
Both TENS and PEMFT, added to conventional physical therapy, were followed by significant within-group reductions in pain (VAS) and carbamazepine dose after 8 weeks.
No statistically significant difference was detected between the TENS and PEMFT groups on either pain scores or carbamazepine intake after treatment.
The trial involved only 56 patients, so this comparison between the two electrotherapy add-ons rests on a small sample.
Source
Medicine
Eid MM, Hamed NS, Abdelbasset WK et al. · 2022
doi: 10.1097/MD.0000000000031433